Inhibition of IL-17A in atherosclerosis

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 471-474

  Cheng, Xiang ^a   Taleb, Soraya ^b   Wang, Jun ^a   Tang, Ting Ting ^a   Chen, Jian ^a   Gao, Xing Li ^a   Yao, Rui ^a   Xie, Jiang Jiao ^a   Yu, Xian ^a   Xia, Ni ^a   Yan, Xin Xin ^a   Nie, Shao Fang ^a   Liao, Meng Yang ^a   Cheng, Yan ^d   Mallat, Ziad ^b,c   Liao, Yu Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSERM   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibody; Atherosclerosis; Bone marrow transplantation; IL 17A; Inflammation

Indexed keywords

CHOLESTEROL; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL; WILD TYPE;

ANIMALS; ANTIBODIES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FEMALE; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; PLAQUE, ATHEROSCLEROTIC; RATS; RECEPTORS, LDL; SIGNAL TRANSDUCTION;

EID: 79953053438     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.12.034     Document Type: Article

References (11)

1. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051-1057.
2. Cheng X., Yu X., Ding Y.J., et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008, 127:89-97.
3. Eid R.E., Rao D.A., Zhou J., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
4. Xie J.J., Wang J., Tang T.T., et al. The Th17/Treg functional imbalance during atherogenesis in ApoE-/- mice. Cytokine 2010, 49:185-193.
5. Erbel C., Chen L., Bea F., et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 2009, 183:8167-8175.
6. Taleb S., Romain M., Ramkhelawon B., et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009, 206:2067-2077.
7. van Es T., van Puijvelde G.H., Ramos O.H., et al. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 2009, 388:261-265.
8. Smith E., Prasad K.M., Butcher M., et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010, 121:1746-1755.
9. Lei J., He F., Wu M., et al. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival. Transpl Int 2010, July 14 [Epub ahead of print].
10. Yu Q., Horak K., Larson D.F. Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 2006, 48:98-104.
11. Ait-Oufella H., Herbin O., Bouaziz J.D., et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010, July 5 [Epub ahead of print].